NASDAQ:HTBX Heat Biologics (HTBX) Stock Price, News & Analysis → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free HTBX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$2.38▼$2.3852-Week Range N/AVolume43,600 shsAverage Volume171,558 shsMarket Capitalization$61.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Heat Biologics alerts: Email Address Ad DTIWhat is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. About Heat Biologics Stock (NASDAQ:HTBX)Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. Heat Biologics, Inc. has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.Read More Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. HTBX Stock News HeadlinesApril 19, 2024 | investing.comScorpius Holdings Inc (SCPX)March 27, 2024 | markets.businessinsider.comWhat Wall Street expects from Heat Biologics's earningsApril 26, 2024 | DTI (Ad)What is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…October 15, 2023 | washingtonpost.comThese are the places that could become ‘unlivable’ as the Earth warmsSeptember 18, 2023 | abcnews.go.comHeat stroke vs. heat exhaustion: Extreme heat safety tipsSeptember 9, 2023 | usatoday.comWhat are the first signs of heat exhaustion? Here is what to keep an eye out for.September 8, 2023 | usatoday.comHow long does heat exhaustion last? What to know about the heat-related illness.September 2, 2023 | usatoday.comEarth sees warmest July 'by a long shot' in 174 years. What it means for the rest of 2023.April 26, 2024 | DTI (Ad)What is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…August 29, 2023 | pnj.comHeat-related deaths in Florida have increased 88% in 3 years as temps continue to riseAugust 26, 2023 | chicago.suntimes.comHeat got you down? High temps affect mood, work performance, studies showAugust 24, 2023 | usatoday.comExtreme heat kills and maims. Here are some of its victims from across the US.August 23, 2023 | usatoday.com6.5 billion people endured climate-change-driven heat in July, report saysAugust 20, 2023 | foxnews.comHeat will impact central US as thunderstorms forecast across countryAugust 18, 2023 | usatoday.comProtect yourself from extreme heat: 4 experts tips to keep you and your family coolAugust 16, 2023 | bbc.co.ukReducing heat transfers – housesAugust 14, 2023 | usatoday.comHow to protect your car from extreme heat: 10 steps to protect your ride from the sunAugust 1, 2023 | nbcnews.comBiden announces actions to help protect workers affected by extreme heatJuly 29, 2023 | washingtonpost.comHow extreme heat may wreak havoc on your flightJuly 26, 2023 | washingtonpost.comHow our brain tries to beat the heat — and why heatstroke is dangerousJuly 24, 2023 | nytimes.comDangerous Heat Wave Is Forecast to Get WorseJuly 23, 2023 | nytimes.comExtreme Weather Hits Europe, and It’s Not Over YetJuly 18, 2023 | bbc.co.ukThe heat index explained in...90 secondsJuly 17, 2023 | usatoday.comTexas postal worker collapses, dies amid extreme heat index over 110July 16, 2023 | usatoday.comGraphics: How to keep cool and recognize the warnings signs of heatstrokeJuly 15, 2023 | usatoday.comEarth's very hot week explained: Where was it so hot?July 15, 2023 | cbsnews.comMore extreme heat is in the forecast. Here's expert advice to prevent heat stroke and other hot weather health hazards.See More Headlines Receive HTBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heat Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:HTBX CUSIPN/A CIK1476963 Webwww.heatbio.com Phone919 240 7133FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares25,650,000Free FloatN/AMarket Cap$61.05 million OptionableOptionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Jeffrey Alan Wolf J.D. (Age 59)Founder, Chairman, CEO & Pres Comp: $1.31MMr. William L. Ostrander (Age 54)CFO & Sec. Comp: $371.07kDr. Justin Stebbing FRCPFRCPath, M.A., M.D., Ph.D., Chief Medical Advisor and Member of Scientific & Clinical Advisory BoardColonel George E. Peoples Jr.F.A.C.S., FACS, M.D., Chief Medical AdvisorDr. Anthony M. Manning Ph.D. (Age 60)Chief Scientific Advisor Dr. Paul W. Tebbey M.B.A.Ph.D., Sr. VP of Product Devel. & Portfolio StrategyMore ExecutivesKey CompetitorsLianBioNASDAQ:LIANTevogen BioNASDAQ:TVGNbluebird bioNASDAQ:BLUEKinnate BiopharmaNASDAQ:KNTENGM BiopharmaceuticalsNASDAQ:NGMView All Competitors HTBX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Heat Biologics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Heat Biologics investors own include Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Vaxart (VXRT), Bionano Genomics (BNGO), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Novan (NOVN) and VBI Vaccines (VBIV). This page (NASDAQ:HTBX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heat Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
